Status:

COMPLETED

Pediatric Cardiac Output Monitoring Observational Study

Lead Sponsor:

Edwards Lifesciences

Conditions:

Pediatric ALL

Eligibility:

All Genders

12-18 years

Brief Summary

To assess Cardiac Output Monitoring in pediatric subjects by comparing FloTrac and ClearSight system to intermittent thermodilution Swan-Ganz, in order to expand the indications of FloTrac, ClearSight...

Eligibility Criteria

Inclusion

  • Subjects who are 12 to 18 years of age
  • Subjects who have signed the Informed Consent Form
  • Subjects who are projected to receive Swan-Ganz catheter as part of procedure/standard of care with intermittent cardiac output measures
  • For those Subjects who have had a cardiac transplant,Subjects who are at least 2 weeks post cardiac transplantation
  • Subjects with planned pressure monitoring with an arterial line

Exclusion

  • Subjects with contraindications for Pulmonary Artery Catheters Placement and monitoring (recurrent sepsis, or with hypercoagulopathy);
  • Subjects with contraindications for Arterial Line Placement;
  • Subjects with an extreme contraction of the smooth muscle in the arteries and arterioles in the lower arm and hand (i.e., Raynaud's Disease).
  • Subjects with a physical site area too limited for proper Sensor placement
  • Subjects with finger size less than the smallest finger cuff size
  • Documented ≥ moderate pulmonary hypertension (PAPm \> 25mmHg, PVRI \> 3.0 WUxm2)
  • Presence of intracardiac shunting (i.e., ASD, VSD)
  • Aorto-pulmonary collaterals
  • ≥ Moderate tricuspid regurgitation, per echocardiogram criteria
  • \> Moderate Aortic or pulmonary regurgitation, per echocardiogram criteria
  • Persistent cardiac arrythmias during the cardiac catheterization period (\> 3min)
  • Vascular abnormalities of the arterial system (i.e., connective tissue disorders, mid-aortic syndrome)

Key Trial Info

Start Date :

September 2 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 5 2023

Estimated Enrollment :

89 Patients enrolled

Trial Details

Trial ID

NCT04465370

Start Date

September 2 2020

End Date

January 5 2023

Last Update

November 18 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

UF Health Shands Children's Hospital

Gainesville, Florida, United States, 32610

2

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

3

Texas Children's Hospital

Houston, Texas, United States, 77030